ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
about
The pivotal role of pathology in the management of lung cancerA comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotypeExpression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitationsSubtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.Therapeutic biomarkers in lung neuroendocrine neoplasia.Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.Classification of different patterns of pulmonary adenocarcinomas.The impact of immunohistochemistry on the classification of lung tumors.Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis.Utility and pattern of positivity of p40 in the diagnosis of squamous cell carcinoma of the lung by cytology: the first study on fine needle aspiration smears.Classification of pulmonary neuroendocrine tumors: new insights.Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
P2860
Q27010437-E04BF8E8-F8E0-4FFC-A592-EC84E16D32EFQ35032336-30A5FB5E-EE6D-4D53-9D71-592CC56CAC85Q36152375-C48E287A-2CF1-4106-B00C-7B02DCC871FBQ38112386-33A22944-6ED5-4AD5-8682-1112261834B1Q38253997-FF4603DA-CA47-403E-BA06-E3B47F1DEE29Q38382493-06B8F299-85C6-4BF0-A51C-10DCAFB51154Q38574971-DD6BB9AC-C99D-480F-A274-66EAC7F5104FQ38822314-2235A0FF-11BE-43BC-A866-20FF09171F1EQ42256127-F9282E8F-324B-49B5-915D-159338DA352DQ42510392-90260AC3-6628-4916-9C67-F6AD463F60BEQ44988491-08FA3FC6-D993-4025-8957-AF07297EB979Q45140096-72825FC8-A923-4501-95D1-42D190EC95BDQ45276482-A88C8B7A-C3CB-45FE-810D-CF4DD105B422Q46891964-06F79CA7-246E-497B-A5A1-A3DBD154436EQ47813304-2B117E62-A4E0-4BFA-96F0-B9B83E1DA0C3Q51643436-B5087778-F027-47EC-AE53-1C091931C6F0
P2860
ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
ΔNp63 (p40) distribution insid ...... ach to tumor characterization.
@en
type
label
ΔNp63 (p40) distribution insid ...... ach to tumor characterization.
@en
prefLabel
ΔNp63 (p40) distribution insid ...... ach to tumor characterization.
@en
P2093
P2860
P50
P356
P1476
ΔNp63 (p40) distribution insid ...... ach to tumor characterization.
@en
P2093
Giulio Rossi
Giuseppe Pelosi
Mattia Barbareschi
Mauro Papotti
P2860
P304
P356
10.1177/1066896913476750
P50
P577
2013-03-12T00:00:00Z